Business Description
Aileron Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US00887A1051
Description
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 367.75 | |||||
| Equity-to-Asset | 0.48 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 34.3 | |||||
| 3-Year EPS without NRI Growth Rate | 35.7 | |||||
| 3-Year FCF Growth Rate | 28.4 | |||||
| 3-Year Book Growth Rate | -36.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 17.43 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.54 | |||||
| 9-Day RSI | 37.1 | |||||
| 14-Day RSI | 37.83 | |||||
| 6-1 Month Momentum % | 5.84 | |||||
| 12-1 Month Momentum % | 104.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | |||||
| Quick Ratio | 3.3 | |||||
| Cash Ratio | 3.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -30.7 | |||||
| Shareholder Yield % | -0.03 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -86.47 | |||||
| ROA % | -33.87 | |||||
| ROIC % | -42.69 | |||||
| ROC (Joel Greenblatt) % | -259798.25 | |||||
| ROCE % | -36.07 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.18 | |||||
| EV-to-EBIT | -1.29 | |||||
| EV-to-EBITDA | -1.29 | |||||
| EV-to-FCF | -1.37 | |||||
| Earnings Yield (Greenblatt) % | -77.52 | |||||
| FCF Yield % | -46.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ALRN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aileron Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.15 | ||
| Beta | 2.11 | ||
| Volatility % | 120.68 | ||
| 14-Day RSI | 37.83 | ||
| 14-Day ATR ($) | 0.353942 | ||
| 20-Day SMA ($) | 3.293 | ||
| 12-1 Month Momentum % | 104.12 | ||
| 52-Week Range ($) | 1.61 - 7.42 | ||
| Shares Outstanding (Mil) | 21.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aileron Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aileron Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aileron Therapeutics Inc Frequently Asked Questions
What is Aileron Therapeutics Inc(ALRN)'s stock price today?
The current price of ALRN is $2.74. The 52 week high of ALRN is $7.42 and 52 week low is $1.61.
When is next earnings date of Aileron Therapeutics Inc(ALRN)?
The next earnings date of Aileron Therapeutics Inc(ALRN) is 2025-02-14 Est..
Does Aileron Therapeutics Inc(ALRN) pay dividends? If so, how much?
Aileron Therapeutics Inc(ALRN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers